| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Zimmer Biomet Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$101.50 |
| 52 Week High | US$122.05 |
| 52 Week Low | US$92.20 |
| Beta | 1.02 |
| 11 Month Change | 6.89% |
| 3 Month Change | 5.16% |
| 1 Year Change | 2.80% |
| 33 Year Change | -12.42% |
| 5 Year Change | -21.92% |
| Change since IPO | 123.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZIM | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.5% | 4.6% | -1.4% |
| 1Y | 2.8% | 0.4% | 11.8% |
Return vs Industry: ZIM exceeded the German Medical Equipment industry which returned -3.3% over the past year.
Return vs Market: ZIM underperformed the German Market which returned 13.9% over the past year.
Price Volatility
| ZIM volatility | |
|---|---|
| ZIM Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ZIM has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: ZIM's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 18,000 | Ivan Tornos | www.zimmerbiomet.com |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products.
Zimmer Biomet Holdings, Inc. Fundamentals Summary
| ZIM fundamental statistics | |
|---|---|
| Market cap | €20.20b |
| Earnings (TTM) | €1.01b |
| Revenue (TTM) | €7.08b |
20.2x
P/E Ratio2.9x
P/S RatioIs ZIM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZIM income statement (TTM) | |
|---|---|
| Revenue | US$7.60b |
| Cost of Revenue | US$2.13b |
| Gross Profit | US$5.46b |
| Other Expenses | US$4.38b |
| Earnings | US$1.08b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.44 |
| Gross Margin | 71.90% |
| Net Profit Margin | 14.27% |
| Debt/Equity Ratio | 53.6% |
How did ZIM perform over the long term?
See historical performance and comparison